Neostigmine Methylsulfate (Cantrell Drug Company)
Welcome to the PulseAid listing for the Neostigmine Methylsulfate drug offered from Cantrell Drug Company. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cantrell Drug Company |
NON-PROPRIETARY NAME: | Neostigmine Methylsulfate |
SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2015-02-03 |
END MARKETING DATE: | 0000-00-00 |
Neostigmine Methylsulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Neostigmine Methylsulfate from Cantrell Drug Company |
LABELER NAME: | Cantrell Drug Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2015-02-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52533-046_21a6eba5-688b-4333-9b1f-63f5323a19e8 |
PRODUCT NDC: | 52533-046 |
APPLICATION NUMBER: | |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers: